PE/VC investors
Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.
Investors (6,250)
Investor
Description
More information
Sodexo Ventures
Sodexo is the global leader in services that improve Quality of Life, an essential factor in individual and organizational performance. Operating in 67 countries, Sodexo serves 100 million consumers each day through its unique combination of On-site Services, Benefits and Rewards Services and Personal and Home Services. Through its more than 100 services, Sodexo provides clients an integrated offering developed over 50 years of
<br />
experience: from foodservices, reception, maintenance and cleaning, to facilities and equipment management; from services and programs fostering employees’ engagement to solutions that simplify and optimize their mobility and expenses management to in-home assistance, child care centers and concierge services. Sodexo’s success and performance are founded on its independence, its sustainable business model and its ability to continuously develop and engage its 470,000 employees throughout the world.
SOFAZ (State Oil Fund of the Republic of Azerbaijan)
![SOFAZ (State Oil Fund of the Republic of Azerbaijan)]()
Azerbaijan is well-known worldwide as an ancient oil country. From the late 19th to the early 20th century, Baku has transformed into one of the biggest oil centres in the world.
After Azerbaijan gained its independence, oil played a crucial role in the country’s development. At the time, the country suffered from military aggression and faced a multitude of different risks. To rebuild the country, the national leader Heydar Aliyev developed a long-term oil strategy. The three pillars of this strategy include:
the attraction of foreign investments and expertise
establishment of multi-optional export routes
efficient and transparent management of accumulated revenues
On September 20, 1994, Azerbaijan signed the Azeri-Chirag-Gunashli Production Sharing Agreement (PSA) with leading international oil companies. Dubbed the “Contract of the Century,” this agreement spurred the signing of new oil contracts, which generated substantial revenues for the country. These developments urged the need to establish an entity whereby assets could be accumulated and efficiently managed. Ilham Aliyev, the vice-president of SOCAR back then, initiated the realization of this idea. As proposed by Ilham Aliyev, the experiences of similar sovereign wealth funds abroad were thoroughly evaluated.
Consequently, the national leader Heydar Aliyev signed a Decree to establish the State Oil Fund of the Republic of Azerbaijan (SOFAZ) on December 29, 1999.
SOFAZ is an extra-budgetary fund and functions as a legal entity separate from the government or central bank. SOFAZ safeguards and prudently manages energy-related earnings for present and future generations. One of the key principles of SOFAZ is transparency. Throughout this period, the Fund has developed institutionally and became an internationally recognized asset management organization.
Sofia Fund
Sofia Fund invests in and grows exceptional women-led companies – those with strong leaders and highly compelling business models that are scalable and meet a market need – to maximize returns for investors. Sofia Fund uses a rigorous process for selecting and investing in high-growth opportunities. Its team of professional women angel investors actively manages and supports its portfolio businesses, leveraging deep expertise and broad networks to help women entrepreneurs achieve success.
<br />
<br />
Sofia Fund uncovers and qualifies only the best investment opportunities from thousands of ideas through extensive due diligence and then actively invests to grow its portfolio companies and bring them successfully to profitable exits.
Sofimac Innovation
![Sofimac Innovation]()
We are an independent management company approved by the AMF and dedicated to technological and innovative investment. We invest in a wide variety of technology sectors and support innovative start-ups in their growth projects through a wide range of investment vehicles.
We manage Funds subscribed by some of the most prestigious public and private institutional investors and have more than 90 companies active in our Portfolio.
Our team is based in Paris, Lyon, Rennes and Marseille, as close as possible to the major innovation centers in France, and brings together 10 experienced investors-entrepreneurs specialized in their field.
Sofina
Sofina is a Belgium-based investment company listed on the Brussels stock exchange and a supportive partner of entrepreneurs and families managing growing companies. Founded more than 120 years ago as an engineering conglomerate, Sofina is now a listed investment company with equity holdings in Europe, the United States and Asia, and across many sectors with a particular focus on consumer and retail, digital transformation, education and healthcare
Sofindev Management NV
Sofindev was founded by Sofina and Colruyt in 1991 and is therefore one of the oldest independent private equity funds in Belgium. Since 1991, the Sofindev shareholders have invested more than 150 MEUR through 3 funds: Sofindev I, Sofindev II (°2002) and Sofindev III (°2006) in more than 40 Belgian companies. In May 2015, a new Sofindev fund, Sofindev IV, has been created.
<br />
<br />
Sofina and Colruyt, the founders of Sofindev, have been the cornerstone investors in Sofindev funds for more than 25 years. Both companies are listed on Euronext Brussels. Sofina is a Belgian listed financial holding company with the Boël family as reference shareholder. Colruyt Group is one of the largest food retail groups in Belgium, with the Colruyt family as reference shareholder. The Colruyt family is also a direct investor in Sofindev funds through the family investment company Korys.
Sofinnova
Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, the firm brings together 12 highly experienced investment professionals from all over Europe, the US and China. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs. Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs, and has backed nearly 500 companies over more than 40 years, creating market leaders around the globe.
Sofinnova Investments
![Sofinnova Investments]()
Sofinnova: At the Intersection of Life Science, Finance & Innovation
Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a clinical-stage biopharmaceutical investment firm with approximately $2.6B in assets under management and committed capital.* We invest in both private and public equity of therapeutics-focused companies.
Our Mission: to improve the lives of patients through science. We strive to provide outstanding results for those we serve: patients, entrepreneurs, and the investors that entrust us with their capital.
Historically Helping
We are long-term investors with an extensive track record of helping the world’s most transformative therapies come to fruition. From drug development and navigating the regulatory process to company building and IPO, we strive to be collaborative, meaningful board members, and excellent partners at every level.
Exploring Possibilities
Sofinnova invests in late preclinical and clinical therapeutic companies across the U.S. and Europe. Key therapeutic areas include oncology, respiratory, dermatology, ophthalmology, neurology and women’s health. We actively partner with entrepreneurs in both the U.S. and Europe who want to rewrite the quality of healthcare today for a better life tomorrow.
One Name, Two Firms
Sofinnova began in 1976 as the U.S. affiliate of the Paris-based Sofinnova Partners. In 1997, the two firms split to become independent entities. Sofinnova Ventures in the US and Sofinnova Partners in France. In 2007, Sofinnova Ventures further refined the investment strategy to be primarily focused on investing in private biopharmaceuticals companies. In 2017, we introduced a public equity strategy focused on global therapeutics. Subsequently, in 2019, we changed our name to Sofinnova Investments to reflect having both public and private strategies in biopharmaceuticals.
Sofinnova Investments: Funding Tomorrow’s Cures.
Sofipaca Capital Investissement
Sofipaca is a subsidiary of the Crédit Agricole Alpes Provence and Provence Côte d'Azur Regional Banks. Sofipaca assists companies located in the PACA region in their projects of: - Capital Development, - Capital Transmission, - Shareholding restructuring. A long-term financial investor and minority shareholder, Sofipaca adapts to each company's project and participates in strategic thinking and their implementation.
<br />
<br />
website
Softbank
SoftBank Group Corp. provides telecommunication services. The Company also operates ADSL (Asymmetric Digital Subscriber Line) and fiber optic high-speed Internet connection, e-Commerce businesses, and Internet based advertising and auction businesses.
